Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Colorectal Neoplasms 17Neoplasm Metastasis 8Rectal Neoplasms 6Colonic Neoplasms 4Uveal Melanoma 3Stomach Neoplasms 2Neoplasms 2Recurrence 1Pancreatic Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Carcinoid Tumor 1Breast Neoplasms 1Biliary Tract Neoplasms 1Advanced Colorectal Cancer 1

Interventions

Ipilimumab 17Nivolumab 15incomplete Freund's adjuvant 8Cyclophosphamide 7CTLA-4 Antigen 7pembrolizumab 6Ranibizumab 6sargramostim 5Radiosurgery 5Blood Specimen Collection 5tebentafusp 4Temozolomide 4Surveys and Questionnaires 4Magnetic Resonance Spectroscopy 4MART-1 Antigen 4Granulocyte-Macrophage Colony-Stimulating Factor 4Biopsy 4Bevacizumab 4fludarabine phosphate 3fludarabine 3aflibercept 3Thalidomide 3Sunitinib 3Specimen Handling 3MAGEA3 protein, human 3Interleukin-2 3130-nm albumin-bound paclitaxel 3relatlimab 2olaparib 2montanide ISA 51 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Uveal Melanoma × aflibercept × Clear all
NCT06121180 2025-12-04

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting
32 enrolled
Dermatologic

Uveal Melanoma

NCT03712904 2025-09-24

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

Thomas Jefferson University

Phase 2 Terminated
3 enrolled 9 charts
Dermatologic

Uveal Melanoma

NCT03172299 2025-03-24

PROTECT

Centre Hospitalier Universitaire de Nice

Phase 3 Completed
57 enrolled
Dermatologic

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡